Stock Price Quote

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE810.458.5 (+1.06 %)
PREV CLOSE ( ) 801.95
OPEN PRICE ( ) 810.00
BID PRICE (QTY) 810.35 (63)
OFFER PRICE (QTY) 810.45 (49)
VOLUME 177374
TODAY'S LOW / HIGH ( )801.55 821.90
52 WK LOW / HIGH ( )281.15 819.55
NSE805.053.15 (+0.39 %)
PREV CLOSE( ) 801.90
OPEN PRICE ( ) 809.00
BID PRICE (QTY) 805.05 (150)
OFFER PRICE (QTY) 805.20 (169)
VOLUME 4236116
TODAY'S LOW / HIGH( ) 801.05 822.00
52 WK LOW / HIGH ( )288.85 819.75
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

25Jun Aurobindo Pharma developing range of p
Aurobindo Pharma is developing a range of products including 14 biosimil..
23Jun M&M, Maruti Suzuki and Karnataka Bank
Mahindra & Mahindra (M&M) has introduced its new Sarpanch Plus r..
23Jun Aurobindo Pharma jumps on planning to
Aurobindo Pharma is currently trading at Rs. 810.00, up by 23.60 points..
22Jun Aurobindo Pharma planning to launch 50
Aurobindo Pharma is planning to launch 50 to 60 new products in US in FY..
04May Aurobindo Pharma gets USFDA’s nod for
Aurobindo Pharma has received final approval from the US Food and Drug A..

Financials

in Millions
QTR Mar 20 ANNUAL 20
Net Profit7250.418727.4
Gross Profit 8728.9 23777
Operating Profit 1009229437.6
Net Sales 36203.2132664.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7611.00 (1.27%)
M.Cap ( in Cr)17471.84
Pfizer (BSE)
peergroup  4117.45 (0.71%)
M.Cap ( in Cr)18848.07
Astrazeneca Pharma I (BSE)
peergroup  3491.15 (0.78%)
M.Cap ( in Cr)8712.63
Shilpa Medicare (BSE)
peergroup  512.25 (4.99%)
M.Cap ( in Cr)4145.64
Hester Biosciences (BSE)
peergroup  1238.70 (1.95%)
M.Cap ( in Cr)1053.75

Shareholding Pattern

PROMOTERS 52.01%
NON-INSTITUTION 13.16%
MUTUAL FUNDS/UTI 11.95%
FI/BANKS/INSURANCE 0.61%
GOVERNMENT 0%
FII 0%

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. was incorporated in the year 1986. Its today's share price is 801.95. Its current market capitalisation stands at Rs 47258.88 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes Savita Mahajan, Avnit Bimal Singh, M Sitarama Murty, PV Ramprasad Reddy, P Sarath Chandra Reddy, M Madan Mohan Reddy, M Sivakumaran, N Govindarajan, K Nithyananda Reddy, K Ragunathan.

It is listed on the BSE with a BSE Code of 524804 , NSE with an NSE Symbol of AUROPHARMA and ISIN of INE406A01037. It's Registered office is at Plot No. 2,Maitrivihar ,AmeerpetHyderabad-500038, Telangana. Their Registrars are ACC Ltd. It's auditors are BSR & Associates LLP, K Nagaraju & Associates, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)